期刊文献+

联合检测血清CA15-3及外周血DNT细胞在乳腺良、恶性肿瘤鉴别及乳腺恶性肿瘤早期诊断中的应用 被引量:8

Application of Combined Detection of Serum CA15-3 and DNT Cells of Peripheral Blood in Early Diagnosis of Breast Malignant Tumors
下载PDF
导出
摘要 目的探讨乳腺良、恶性肿瘤鉴别和乳腺恶性肿瘤早期诊断的新方法。方法采用流式细胞仪测定乳腺肿瘤患者外周血DNT细胞及血清CA15-3的表达水平。结果血清CA15-3及外周血DNT细胞检测乳腺恶性肿瘤的灵敏度、特异度分别为60.0%、96.3%;55.8%、71.3%。联合血清CA15-3及外周血DNT细胞检测,并联实验将乳腺恶性肿瘤的灵敏度提高至82.3%,串联实验将特异度提高到98.9%。结论利用血清CA15-3与DNT细胞联合检测,将明显提高乳腺恶性肿瘤诊断的灵敏度和特异度,有较大的临床应用价值。 Objective To explore a new method for early diagnosis of breast cancer, and differentiating diagnosis of benign and malignant tumor. Methods The flow cytometry was used to determine the expression levels of DNT cells and CA15-3 in peripheral blood of patients with breast cancer. Results The sensitivity and specificity of serum CA15-3 and peripheral blood DNT cells in the diagnosis of breast cancer were 60% ,96.3% ,55.8%, 71.3 % , respectively. The sensitivity and specificity of combined serum CA15-3 and peripheral blood DNT cells were 82.3% and 98.9%, respectively. Conclusion The combined detection of serum CA15-3 and DNT ceils could improve the sensitivity and specificity with great clinical value for the diagnosis of breast cancer.
出处 《标记免疫分析与临床》 CAS 2016年第1期23-25,共3页 Labeled Immunoassays and Clinical Medicine
基金 河北省邢台市科技局立项课题(项目编号:2015ZC084)
关键词 乳腺肿瘤 血清CA15-3 DNT细胞 流式细胞术 Breast tumor Serum CA15-3 DNT cells Flow cytometry
  • 相关文献

参考文献9

二级参考文献57

  • 1李广太,张士伟.妇科肿瘤患者外周血淋巴细胞亚群研究进展[J].国外医学(妇产科学分册),1993,20(4):194-197. 被引量:18
  • 2张录民,赵维,刘国津.乳腺癌患者血清中CEA和CA153的表达及临床意义[J].第四军医大学学报,2007,28(4):307-309. 被引量:17
  • 3中华医学会检验医学分会肿瘤标志物专家委员会.肿瘤标志物检测临床应用的基本原则(讨论稿)[J].中华检验医学杂志,2004,:27-27.
  • 4王健 吉强 殷建华 等.AFP实验室检测40年[A]..肿瘤标志专题讨论会论文集[C].,2002.27-35.
  • 5Pritzker KH. Cancer biomarkers : easier said than done. Clin Chem, 2002,48: 1147- 1150.
  • 6Fleisher M, Dnistrian AM, Sturgeon CM, et al. Practice guidelines and recommendations for use tumor markers in the clinic. Washington DC: AACC Press,2002.20-25
  • 7Lichtenstein AV, Potapova GI. Genetic defects as tumor markers. Molecular Biol, 2003,37:159-169.
  • 8Lakhani SR, Ashworth A. Microarray and histo-pathological analysis of tumours:the future and the past? Nature Rev Cancer, 2001,1:151-157.
  • 9Yu H, Diamandis EP, Levesque M, et al. Prostate specific antigen in breast cancer benign breast disease and normal breast tissue. Breast Cancer Res Treat, 1996,40:171- 178.
  • 10Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer, 2003,3:267-275.

共引文献147

同被引文献69

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部